Women’s Health USA announced today a new Board of Directors, another move in reinforcing the company’s role as a leading management services organization in the healthcare sector and poising it for meaningful long-term growth. The announcement follows a majority recapitalization event and appointment of a new chief executive officer in 2017 and demonstrates the company’s increasing commitment to being a highly-visible and impactful force in the women’s health care in the U.S.
New Board appointee, Kristin Torres Mowat, brings to Women’s Health USA experience in strategy, corporate development, acquisitions and integrations in the healthcare category. She currently serves as Senior Vice President, Corporate Development for Castlight Health in San Francisco. “I’m honored to join this board and continue to build on the strength Women’s Health USA has established with women’s health practitioners. I’m inspired to bring together an integrated delivery network that will lead the conversation on improving care for women.”
Natasha Deckmann, M.D., brings her clinical and population health management leadership skills, as well as her private equity advisory and operating experience to her new role on the Women’s Health USA board. She has significant background in the healthcare arena having served most recently as Senior Vice President, Head of Population Health Solutions at Optum. “I’m thrilled to be joining the Women’s Health USA team and look forward to playing an active and meaningful role in transforming the health care experience for women, and lowering their total cost of care, across the country.”
“What appeals to me about this role are the myriad opportunities to be truly shaping the delivery model and the conversation in the way this nation cares for women” stated Paul Martino, who will round out the new Board appointees for Women’s Health USA. Paul is Co-Founder of and currently serves as Chief Strategy Officer for VillageMD, a primary care management service organization headquartered in the Chicago area. His key skills sets in clinical strategy, innovation and market leadership will be of significant value in his new role as a Women’s Health USA board member.
Other members of the Women’s Health USA board include current CEO, Goran Dragolovic as well as Robert Patricelli, the former CEO, and David Finley and Gregg Osenkowski from Sverica Capital Management LP.
Women’s Health USA currently partners with OB/GYN, in vitro fertilization, and other specialty women’s health practices in 7 states to implement growth strategies, payer contracting, revenue cycle management, EMR support, financial and human resource management, merger and acquisition support, ancillary services development, marketing and risk management services. With more than 600 physician partners, its unique and successful partnership model enables physicians and physician groups to maintain their independence, while leveraging the resources of a national organization.